PEAPACK, N.J. — Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products.
Greenstone's trandolapril/verapamil hydrochloride tablets is the authorized generic version of Tarka from AbbVie and is used to treat hypertension. Greenstone is offering the tablets in the following dosage strengths: 1mg x 100; 2mg x100; 2mg x 100; and 4mg x 100.